Subscribe to our Newsletters !!

    Dr Reddy’s

    Dr Reddy’s Srikakulam Unit gets EIR from USFDA

    Dr Reddy’s Laboratories said its details plant in Andhra Pradesh got the Establishment Inspection Report (EIR) from the US sedate controller. Dr Reddy’s Laboratories said that its Formulations Srikakulum Plant (SEZ) Unit I in Andhra Pradesh got the foundation review report (EIR) from US Food and Drug Administration (USFDA), demonstrating conclusion of the review. The

    Dr. Reddy’s ascents after Hyderabad office gets EIR from USFDA

    Dr. Reddy’s Laboratories rose 0.71% to Rs 3725.7 after the organization said its definitions producing plant – 3 at Bachupally in Hyderabad got the foundation examination report (EIR) from US medicate controller. Dr. Reddy’s will report Q4 results today, 20 May 2020. The medication creator revealed a united total deficit of Rs 538.40 crore in

    Dr Reddy’s dispatches Avigan (Favipiravir) tablets in India

    Dr Reddy’s Laboratories on August 19 announced the launch of Avigan (Favipiravir) pills, used for treating mild to moderate COVID-19 sufferers in India. Dr Reddy’s stated Avigan was approved by the Drugs Controller General of India (DCGI) for treating patients with moderate to medium COVID-19. “The need for high efficacy and quality, affordability and improved

    Dr Reddy’s’ settles case with Bristol Myers Squibb unit over nonexclusive malignant growth drug

    The Hyderabad-based firm has settled litigation with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb, Dr Reddy”s Laboratories said in a statement. In settlement of all outstanding claims in the litigation, Celgene has agreed to provide the company with a permit to sell volume-limited amounts of generic lenalidomide capsules in america starting on a confidential

    Dr Reddy’s gets 3 perceptions from USFDA for US-based API plant

    Dr Reddy’s Laboratories on Wednesday said the US health regulator has issued a Form 483 with three observations after inspecting its Production facility in Middleburg, New York. The audit of the business’s active pharmaceutical ingredients (API) manufacturing plant at Middleburg, New York has been completed from the US Food and Drug Administration (USFDA), the Hyderabad-based

    Rockwell Industries ties with DRL for freezer to store Sputnik V

    Rockwell Industries, a cold chain appliance manufacturer on Wednesday announced its strategic partnership with Dr Reddy’s Labs, to provide its World Health Organisation – Performance, Quality and Safety certified Covid-19 vaccine freezersto enablestorage of Sputnik V vaccine in India. According to a release by Rockwell, the vaccine freezer plays a very critical role in the safety

    Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19

    India. June 29, 2021 – Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”), Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred to as “Dr. Reddy’s”), Emcure Pharmaceuticals Limited (hereafter referred to as “Emcure”), Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715,